Hormones and AID: Balancing immunity and autoimmunity

Autoimmunity

Volumn 46, Issue 2, 2013, Pages 128-137

  Incorvaia, Elisabetta ^a   Sicouri, Lara ^a   Petersen Mahrt, Svend K ^a   Schmitz, Kerstin Maike ^a  

^a FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

Author keywords

Autoantibodies; Deamination; Epigenetics; Estrogen; Immunoglobulin; Lupus

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; AUTOANTIBODY; ESTROGEN; ESTROGEN RECEPTOR; IMMUNOGLOBULIN; MICRORNA; MICRORNA 155; MICRORNA 181B; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HOXC4; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; DISEASE COURSE; EPSTEIN BARR VIRUS; HORMONE BINDING; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; REVIEW; TRANSCRIPTION REGULATION;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; B-LYMPHOCYTES; CYTIDINE DEAMINASE; GENE EXPRESSION REGULATION; HOMEOSTASIS; HORMONES; HUMANS; IMMUNITY;

EID: 84873674623     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2012.748752     Document Type: Review

References (132)

1. Zerrahn, J., W. Held, and D. H. Raulet. 1997. The MHC reactivity of the T cell repertoire prior to positive and negative selection. Cell 88: 627-636
2. Quintero, O. L., M. J. Amador-Patarroyo, G. Montoya-Ortiz, A. Rojas-Villarraga, and J.-M. Anaya. 2012. Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity. J. Autoimmun 38: J109-J119
3. Nussinovitch, U., and Y. Shoenfeld. 2012. The role of gender and organ specific autoimmunity. Autoimmun. Rev 11: A377-A385
4. Liu, S. M., A. P. R. Sutherland, Z. Zhang, et al. 2012. Overexpression of the Ctla-4 isoform lacking exons 2 and 3 causes autoimmunity. J. Immunol 188: 155-162
5. Walunas, T. L., D. J. Lenschow, C. Y. Bakker, et al. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1: 405-413
6. Fierabracci, A. 2011. Recent insights into the role and molecular mechanisms of the autoimmune regulator (AIRE) gene in autoimmunity. Autoimmun. Rev 10: 137-143
7. Matsumoto, M. 2009. The role of autoimmune regulator (Aire) in the development of the immune system. Microbes Infect 11: 928-934
8. Jeon,M.-S., A. Atfield, K. Venuprasad, et al. 2004. Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction. Immunity 21: 167-177
9. Krammer, P. H. 2000. CD95's deadly mission in the immune system. Nature 407: 789-795
10. Siegel, R. M., F. K. Chan, H. J. Chun, and M. J. Lenardo. 2000. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity.Nature Immunol 1: 469-474
11. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061
12. Flodström-Tullberg, M., Y. T. Bryceson, F.-D. Shi, P. Höglund, and H.-G. Ljunggren. 2009. Natural killer cells in human autoimmunity. Curr. Opin. Immunol 21: 634-640
13. Cusick, M. F., J. E. Libbey, and R. S. Fujinami. 2012. Molecular mimicry as a mechanism of autoimmune disease. Clin. Rev. Allergy Immunol 42: 102-111
14. Lemoine, S., A. Morva, P. Youinou, and C. Jamin. 2009. Regulatory B cells in autoimmune diseases: how do they work? Ann. NY Acad. Sci 1173: 260-267
15. Mariñ o, E., and S. T. Grey. 2012. B cells as effectors and regulators of autoimmunity. Autoimmunity 45: 377-387
16. Grimaldi, C. M., R. Hicks, and B. Diamond. 2005. B cell selection and susceptibility to autoimmunity. J. Immunol 174: 1775-1781
17. Königsberger, S., J. Prodö hl, D. Stegner, et al. 2012. Altered BCR signalling quality predisposes to autoimmune disease and a pre-diabetic state. EMBO J 31: 3363-3374
18. Goodnow, C. C. 2007. Multistep pathogenesis of autoimmune disease. Cell 130: 25-35
19. Meffre, E., and H. Wardemann. 2008. B-cell tolerance checkpoints in health and autoimmunity. Curr. Opin. Immunol 20: 632-638
20. Atassi, M. Z., and P. Casali. 2008. Molecular mechanisms of autoimmunity. Autoimmunity 41: 123-132
21. Lleo, A., P. Invernizzi, B. Gao, M. Podda, and M. E. Gershwin. 2010. Definition of human autoimmunity-autoantibodies versus autoimmune disease. Autoimmun. Rev 9: A259-A266
22. Kronenberg, M., and A. Rudensky. 2005. Regulation of immunity by self-reactive T cells. Nature 435: 598-604
23. Rada, C., and C. Milstein. 2001. The intrinsic hypermutability of antibody heavy and light chain genes decays exponentially. EMBO J 20: 4570-4576
24. Saribasak, H., and P. J. Gearhart. 2012. Does DNA repair occur during somatic hypermutation? Semin. Immunol 24: 287-292
25. Xu, Z., H. Zan, E. J. Pone, T. Mai, and P. Casali. 2012. Immunoglobulin class-switch DNA recombination: induction, targeting and beyond. Nat. Rev. Immunol 12: 517-531
26. Di Noia, J. M., and M. S. Neuberger. 2007. Molecular mechanisms of antibody somatic hypermutation. Annu. Rev. Biochem 76: 1-22
27. Stavnezer, J., J. Guikema, and C. Schrader. 2008. Mechanism and regulation of class switch recombination. Annu. Rev. Immunol 26: 261-292
28. Peters, A., and U. Storb. 1996. Somatic hypermutation of immunoglobulin genes is linked to transcription initiation. Immunity 4: 57-65
29. Willmann, K. L., S. Milosevic, S. Paulkin, et al. 2012. A role for the RNA pol II-associated PAF complex in AID-induced immune diversification. J. Exp. Med 209: 2099-2111
30. Basu, U., F.-L. Meng, C. Keim, et al. 2011. The RNA exosome targets the AID cytidine deaminase to both strands of transcribed duplex DNA substrates. Cell 144: 353-363
31. Pavri, R., A. Gazumyan, M. Jankovic, et al. 2010. Activationinduced cytidine deaminase targets DNA at sites of RNA polymerase II stalling by interaction with Spt5. Cell 143: 122-133
32. Stanlie, A., N. A. Begum, H. Akiyama, and T. Honjo. 2012. The DSIF subunits Spt4 and Spt5 have distinct roles at various phases of immunoglobulin class switch recombination. PLoS Genet 8: e1002675
33. Petersen-Mahrt, S. 2005. DNA deamination in immunity. Immunol. Rev 203: 80-97
34. Beale, R. C. L., S. K. Petersen-Mahrt, I. N.Watt, et al. 2004. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo. J. Mol. Biol 337: 585-596
35. Bransteitter, R., P. Pham, M.D. Scharff, and M. F. Goodman. 2003. Activation-induced cytidine deaminase deaminates deoxycytidine on single-strandedDNAbut requires the action of RNase. Proc. Natl. Acad. Sci. USA 100: 4102-4107
36. Morgan, H. D., W. Dean, H. A. Coker, W. Reik, and S. K. Petersen-Mahrt. 2004. Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming. J. Biol. Chem 279: 52353-52360
37. Harris, R. S., K. N. Bishop, A. M. Sheehy, et al. 2003. DNA deamination mediates innate immunity to retroviral infection. Cell 113: 803-809
38. Harris, R. S., S. K. Petersen-Mahrt, and M. S. Neuberger. 2002. RNA editing enzyme APOBEC1 and some of its homologs can act asDNAmutators.Mol Cell 10: 1247-1253
39. Petersen-Mahrt, S. K., and M. S. Neuberger. 2003. In vitro deamination of cytosine to uracil in single-stranded DNA by apolipoprotein B editing complex catalytic subunit 1 (APOBEC1). J. Biol. Chem 278: 19583-19586
40. Pauklin, S., I. V. Sernández, G. Bachmann, A. R. Ramiro, and S. K. Petersen-Mahrt. 2009. Estrogen directly activates AID transcription and function. J. Exp. Med 206: 99-111
41. Rada, C., J. M. Jarvis, and C. Milstein. 2002. AID-GFP chimeric protein increases hypermutation of Ig genes with no evidence of nuclear localization. Proc. Natl. Acad. Sci. USA 99: 7003-7008
42. Brar, S. S., M. Watson, and M. Diaz. 2004. Activationinduced cytosine deaminase (AID) is actively exported out of the nucleus but retained by the induction of DNA breaks. J. Biol. Chem 279: 26395-26401
43. Ito, S., H. Nagaoka, R. Shinkura, et al. 2004. Activationinduced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1. Proc. Natl. Acad. Sci. USA 101: 1975-1980
44. Patenaude, A. M., A. Orthwein, Y. Hu, et al. 2009. Active nuclear import and cytoplasmic retention of activationinduced deaminase. Nat. Struct. Mol. Biol 16: 517-527
45. Revy, P., T. Muto, Y. Levy, et al. 2000. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102: 565-575
46. Pasqualucci, L., R. Guglielmino, J. Houldsworth, et al. 2004. Expression of the AID protein in normal and neoplastic B cells. Blood 104: 3318-3325
47. Ramiro, A. R., M. Jankovic, E. Callen, et al. 2006. Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. Nature 440: 105-109
48. Ramiro, A. R., M. Jankovic, T. Eisenreich, et al. 2004. AID is required for c-myc/IgH chromosome translocations in vivo. Cell 118: 431-438
49. Endo, Y., H. Marusawa, K. Kinoshita, et al. 2007. Expression of activation-induced cytidine deaminase in human hepatocytes via NF-kappaB signaling. Oncogene 26: 5587-5595
50. Okazaki, I.-m., H. Hiai, N. Kakazu, et al. 2003. Constitutive expression of AID leads to tumorigenesis. J Exp Med 197: 1173-1181
51. Takai, A., T. Toyoshima, M. Uemura, et al. 2009. A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations. Oncogene 28: 469-478
52. Häsler, J., C. Rada, and M. S. Neuberger. 2012. The cytoplasmic AID complex. Semin. Immunol 24: 273-280
53. Larijani, M., and A. Martin. 2012. The biochemistry of activation-induced deaminase and its physiological functions. Semin. Immunol 24: 255-263
54. Orthwein, A., and J. M. Di Noia. 2012. Activation induced deaminase: How much and where? Semin. Immunol 24: 246-254
55. Vuong, B. Q., and J. Chaudhuri. 2012. Combinatorial mechanisms regulating AID-dependent DNA deamination: Interacting proteins and post-translational modifications. Semin. Immunol 24: 264-272
56. Dedeoglu, F., B. Horwitz, J. Chaudhuri, F. W. Alt, and R. S. Geha. 2004. Induction of activation-induced cytidine deaminase gene expression by IL-4 and CD40 ligation is dependent on STAT6 and NFkappaB. Int. Immunol 16: 395-404
57. Gonda, H., M. Sugai, Y. Nambu, et al. 2003. The balance between Pax5 and Id2 activities is the key to AID gene expression. J Exp Med 198: 1427-1437
58. Xu, Z., E. J. Pone, A. Al-Qahtani, et al. 2007. Regulation of aicda expression and AID activity: relevance to somatic hypermutation and class switch DNA recombination. Crit. Rev. Immunol 27: 367-397
59. Dorsett, Y., K. M. McBride, M. Jankovic, et al. 2008. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity 28: 630-638
60. de Yébenes, V. G., L. Belver, D. G. Pisano, et al. 2008. miR-181b negatively regulates activation-induced cytidine deaminase in B cells. J. Exp. Med 205: 2199-2206
61. Mai, T., H. Zan, J. Zhang, et al. 2010. Estrogen receptors bind to and activate the HOXC4/HoxC4 promoter to potentiate HoxC4-mediated activation-induced cytosine deaminase induction, immunoglobulin class switch DNA recombination, and somatic hypermutation. J. Biol. Chem 285: 37797-37810
62. Pauklin, S., and S. K. Petersen-Mahrt. 2009. Progesterone inhibits activation-induced deaminase by binding to the promoter. J. Immunol 183: 1238-1244
63. Whitacre, C. C. 2001. Sex differences in autoimmune disease. Nat. Immunol 2: 777-780
64. Whitacre, C. C., S. C. Reingold, and P. A. O'Looney. 1999. A gender gap in autoimmunity. Science 283: 1277-1278
65. Peeva, E., and M. Zouali. 2005. Spotlight on the role of hormonal factors in the emergence of autoreactive B-lymphocytes. Immunol. Lett 101: 123-143
66. Medina, K. L., G. Smithson, and P. W. Kincade. 1993. Suppression of B lymphopoiesis during normal pregnancy. J. Exp. Med 178: 1507-1515
67. Smithson, G., W. G. Beamer, K. L. Shultz, et al. 1994. Increased B lymphopoiesis in genetically sex steroid-deficient hypogonadal (hpg) mice. J. Exp. Med 180: 717-720
68. Carlsten, H., R. Holmdahl, A. Tarkowski, and L. A. Nilsson. 1989. Oestradiol-and testosterone-mediated effects on the immune system in normal and autoimmune mice are genetically linked and inherited as dominant traits. Immunology 68: 209-214
69. Erlandsson, M. C., C. A. Jonsson, U. Islander, C. Ohlsson, and H. Carlsten. 2003. Oestrogen receptor specificity in oestradiol-mediated effects on B lymphopoiesis and immunoglobulin production in male mice. Immunology 108: 346-351
70. Roubinian, J.,N. Talal, P. K. Siiteri, and J. A. Sadakian. 1979. Sex hormone modulation of autoimmunity in NZB/NZW mice. Arthritis Rheum 22: 1162-1169
71. Carlsten, H., A. Tarkowski, R. Holmdahl, and L. A. Nilsson. 1990. Oestrogen is a potent disease accelerator in SLE-prone MRL lpr/lpr mice. Clin Exp Immunol 80: 467-473
72. Verthelyi, D., and S. A. Ahmed. 1994. 17 beta-estradiol, but not 5 alpha-dihydrotestosterone, augments antibodies to double-stranded deoxyribonucleic acid in nonautoimmune C57BL/6J mice. Endocrinology 135: 2615-2622
73. Li, J., and R. W. McMurray. 2007. Effects of estrogen receptor subtype-selective agonists on autoimmune disease in lupus-prone NZB/NZW F1 mouse model. Clin. Immunol 123: 219-226
74. Bynoe, M. S., C. M. Grimaldi, and B. Diamond. 2000. Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells. Proc. Natl. Acad. Sci. USA 97: 2703-2708
75. Beagley,K.W., and C. M. Gockel. 2003. Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone. FEMS Immunol. Med. Microbiol 38: 13-22
76. Kanda, N., T. Tsuchida, and K. Tamaki. 1999. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheumat 42: 328-337
77. Mantalaris, A., N. Panoskaltsis, Y. Sakai, et al. 2001. Localization of androgen receptor expression in human bone marrow. J. Pathol 193: 361-366
78. Cutolo, M., E. Balleari, S. Accardo, et al. 1984. Preliminary results of serum androgen level testing in men with rheumatoid arthritis. Arthritis Rheum 27: 958-959
79. Cutolo, M. 2009. Androgens in rheumatoid arthritis: when are they effectors? Arthritis Res. Ther 11: 126
80. Theofilopoulos, A. N., and F. J. Dixon. 1985. Murine models of systemic lupus erythematosus.Adv.Immunol 37: 269-390
81. Zan, H., J. Zhang, S. Ardeshna, et al. 2009. Lupus-prone MRL/faslpr/lpr mice display increased AID expression and extensive DNA lesions, comprising deletions and insertions, in the immunoglobulin locus: concurrent upregulation of somatic hypermutation and class switch DNA recombination. Autoimmunity 42: 89-103
82. Jiang, C., J. Foley, N. Clayton, et al. 2007. Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice. J. Immunol 178: 7422-7431
83. Mountz, J. D., P. Yang, Q. Wu, et al. 2005. Genetic segregation of spontaneous erosive arthritis and generalized autoimmune disease in the BXD2 recombinant inbred strain of mice. Scand. J. Immunol 61: 128-138
84. Hsu, H.-C., Y. Wu, P. Yang, et al. 2007. Overexpression of activation-induced cytidine deaminase in B cells is associated with production of highly pathogenic autoantibodies. J. Immunol 178: 5357-5365
85. Jiang, C., M.-L. Zhao, K. M. Waters, and M. Diaz. 2012. Activation-induced deaminase contributes to the antibody-independent role of B cells in the development of autoimmunity. Autoimmunity 45: 440-448
86. Meyers, G., Y. S. Ng, J. M. Bannock, et al. 2011. Activationinduced cytidine deaminase (AID) is required for B-cell tolerance in humans. Proc. Natl. Acad. Sci. USA 108: 11554-11559
87. Chen, L., L. Guo, J. Tian, B. Zheng, and S. Han. 2010. Deficiency in activation-induced cytidine deaminase promotes systemic autoimmunity in lpr mice on a C57BL/6 background. Clin. Exp. Immunol 159: 169-175
88. Agrawal, A., Q. M. Eastman, and D. G. Schatz. 1998. Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system. Nature 394: 744-751
89. Gellert, M., J. E. Hesse, K. Hiom, et al. 1999. V(D)J recombination: links to transposition and double-strand break repair. Cold Spring Harb. Symp. Quant. Biol 64: 161-167
90. Bestor, T. H. 1999. Sex brings transposons and genomes into conflict. Genetica 107: 289-295
91. Popp, C., W. Dean, S. Feng, et al. 2010. Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency. Nature 463: 1101-1105
92. Butterworth, M., B. McClellan, and M. Allansmith. 1967. Influence of sex in immunoglobulin levels. Nature 214: 1224-1225
93. Eidinger, D., and T. J. Garrett. 1972. Studies of the regulatory effects of the sex hormones on antibody formation and stem cell differentiation. J. Exp. Med 136: 1098-1116
94. Macaulay, E. C., R. J.Weeks, S. Andrews, and I. M. Morison. 2011. Hypomethylation of functional retrotransposonderived genes in the human placenta. Mamm. Genome 22: 722-735
95. Schmitz, K.-M., and S. K. Petersen-Mahrt. 2012. AIDing the immune system-DIAbolic in cancer. Semin. Immunol 24: 241-245
96. Nik-Zainal, S., L. B. Alexandrov, D. C. Wedge, et al. 2012. Mutational Processes Molding the Genomes of 21 Breast Cancers. Cell 149: 979-993
97. Stephens, P. J., P. S. Tarpey, H. Davies, et al. 2012. The landscape of cancer genes and mutational processes in breast cancer. Nature 486: 400-404
98. Franchini, D. M., K.M. Schmitz, and S. K. Petersen-Mahrt. 2012. 5-Methylcytosine DNA Demethylation: More than losing a methyl group. Ann. Rev. Gen 46: 419-441
99. Wilks, A. F., P. J. Cozens, I. W. Mattaj, and J. P. Jost. 1982. Estrogen induces a demethylation at the 5' end region of the chicken vitellogenin gene. Proc. Natl. Acad. Sci. USA 79: 4252-4255
100. Metivier, R., G. Huet, R. Gallais, et al. 2008. Dynamics of estrogen receptor-mediated transcriptional activation of responsive genes in vivo: apprehending transcription in four dimensions. Adv. Exp. Med. Biol 617: 129-138
101. Strickland, F. M., A. Hewagama, Q. Lu, et al. 2012. Environmental exposure, estrogen and two X chromosomes are required for disease development in an epigenetic model of lupus. J. Autoimmun 38: 135-143
102. Qin, H., K. Suzuki, M. Nakata, et al. 2011. Activationinduced cytidine deaminase expression in CD4 T cells is associated with a unique IL-10-producing subset that increases with age. PloS One 6: e29141
103. Barreto, G., A. Schäfer, J. Marhold, et al. 2007. Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation. Nature 445: 671-675
104. Schmitz, K.-M., N. Schmitt, U. Hoffmann-Rohrer, et al. 2009. TAF12 recruits Gadd45a and the nucleotide excision repair complex to the promoter of rRNA genes leading to active DNA demethylation. Mol. Cell 33: 344-353
105. Rai, K., I. J. Huggins, S. R. James, et al. 2008. DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and gadd45. Cell 135: 1201-1212
106. Salvador, J. M., M. C. Hollander, A. T. Nguyen, et al. 2002. Mice lacking the p53-effector gene Gadd45a develop a lupuslike syndrome. Immunity 16: 499-508
107. Hui, A. M., W. Zhang, W. Chen, et al. 2004. Agents with selective estrogen receptor (ER) modulator activity induce apoptosis in vitro and in vivo in ER-negative glioma cells. Cancer Res 64: 9115-9123
108. Oki, T., Y. Sowa, T. Hirose, et al. 2004. Genistein induces Gadd45 gene and G2/M cell cycle arrest in the DU145 human prostate cancer cell line. FEBS Lett 577: 55-59
109. Stein, B., and M. X. Yang. 1995. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappaBand C/EBP beta. Mol. Cell. Biol 15: 4971-4979
110. Xing, D., S. Oparil, H. Yu, et al. 2012. Estrogen modulates NFkB signaling by enhancing IkBa levels and blocking p65 binding at the promoters of inflammatory genes via estrogen receptor-b. PLoS ONE 7: e36890
111. White, C. A., J. Seth Hawkins, E. J. Pone, et al. 2011. AID dysregulation in lupus-prone MRL/Fas(lpr/lpr) mice increases class switch DNA recombination and promotes interchromosomal c-Myc/IgH loci translocations: modulation by HoxC4. Autoimmunity 44: 585-598
112. Chadwick, C. C., S. Chippari, E. Matelan, et al. 2005. Identification of pathway-selective estrogen receptor ligands that inhibit NF-kappaB transcriptional activity. Proc. Natl. Acad. Sci. USA 102: 2543-2548
113. Nettles, K.W.,G. Gil, J. Nowak, et al. 2008. CBP Is a dosagedependent regulator of nuclear factor-kappaB suppression by the estrogen receptor. Mol. Endocrinol 22: 263-272
114. Klinge, C. M. 2012. miRNAs and estrogen action. Trends Endocrinol. Metab 23: 223-233
115. Yamagata, K., S. Fujiyama, S. Ito, et al. 2009. Maturation of microRNA is hormonally regulated by a nuclear receptor. Mol. Cell 36: 340-347
116. Belver, L., V. G. de Yébenes, and A. R. Ramiro. 2010. MicroRNAs Prevent the Generation of Autoreactive Antibodies. Immunity 33: 713-722
117. Leng, R.-X., H.-F. Pan, W.-Z. Qin, G.-M. Chen, and D.-Q. Ye. 2011. Role of microRNA-155 in autoimmunity. Cytokine Growth Factor Rev 22: 141-147
118. Olson, J. K., J. L. Croxford, and S. D. Miller. 2001. Virusinduced autoimmunity: potential role of viruses in initiation, perpetuation, and progression of T-cell-mediated autoimmune disease. Viral Immunol 14: 227-250
119. Pender, M. P. 2003. Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. Trends Immunol 24: 584-588
120. Wucherpfennig, K. W. 2001. Mechanisms for the induction of autoimmunity by infectious agents. J. Clin. Invest 108: 1097-1104
121. Tobollik, S., L. Meyer, M. Buettner, et al. 2006. Epstein-Barr virus nuclear antigen 2 inhibits AID expression during EBVdriven B-cell growth. Blood 108: 3859-3864
122. Heath, E., N. Begue-Pastor, S. Chaganti, et al. 2012. Epstein-Barr virus infection of naive B cells in vitro frequently selects clones with mutated immunoglobulin genotypes: implications for virus biology. PLoS Pathog 8: e1002697
123. Igarashi, M., Y. Kawaguchi, K. Hirai, and F. Mizuno. 2003. Physical interaction of Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) with human oestrogenrelated receptor 1 (hERR1): hERR1 interacts with a conserved domain of EBNA-LP that is critical for EBVinduced B-cell immortalization. J. Gen. Virol 84: 319-327
124. Zhang, Z., and C. T. Teng. 2001. Estrogen receptor alpha and estrogen receptor-related receptor alpha1 compete for binding and coactivator.Mol Cell Endocrinol 172: 223-233
125. Crouch, E. E., Z. Li, M. Takizawa, et al. 2007. Regulation of AID expression in the immune response. J. Exp. Med 204: 1145-1156
126. Gourzi, P., T. Leonova, and F. N. Papavasiliou. 2006. A role for activation-induced cytidine deaminase in the host response against a transforming retrovirus. Immunity 24: 779-786
127. Jiang, J., E. J. Lee, and T. D. Schmittgen. 2006. Increased expression of microRNA-155 in Epstein-Barr virus transformed lymphoblastoid cell lines. Genes Chromosomes Cancer 45: 103-106
128. Yin, Q., J. McBride, C. Fewell, et al. 2008. MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways. J. Virol 82: 5295-5306
129. Mü schen, M., D. Re, B. Jungnickel, et al. 2000. Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reaction. J Exp Med 192: 1833-1840
130. Takahashi, T., M. Tanaka, C. I. Brannan, et al. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76: 969-976
131. Cohen, P. L., and R. A. Eisenberg. 1991. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol 9: 243-269
132. Oliveira, J. B., and T. Fleisher. 2004. Autoimmune lymphoproliferative syndrome. Curr. Opin. Allergy Clin. Immunol 4: 497-503